Study reveals that Edaravone prevents the accumulation of toxins that steadily degenerates cells that eventually leads to loss of cognitive functions.

Edaravone prevents the accumulation of toxins that steadily degenerates cells that eventually leads to loss of cognitive functions.
Researchers tested the drug on mice; the team showed that the drug effectively blocks the toxin function of the amyloid beta cells. The drug effectively fights the primary causes of Alzheimer’s disease.
Researchers said that further research is needed to know whether the drug could help people with Alzheimer’s disease. Edaravone cannot be prescribed unless the drug passes human trials in which patients are being specifically treated for Alzheimer’s disease.
Advertisement